- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
Sepsis Diagnostic Market size was valued at USD 585.82 million in 2022 and is poised to grow at a CAGR of 7.62% from 2023-29. Due to increase in prevalence of sepsis which may lead to organ dysfunction and acute alteration in mental status and even it may cause death in severe cases. Moreover, the different procedures of treatment that can cause sepsis are also increasing, and rise in R&D activities for the development of sepsis diagnostics are the major factors that are driving the growth of the global market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global sepsis diagnostic market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global sepsis diagnostic market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global sepsis diagnostic products.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of sepsis is a key factor drive the global sepsis diagnostic market. According to World Health Organization 2018, approximately 6 Mn death occurred due to sepsis around the globe. Moreover, the raise in funding for the R&D activities by public and private sectors, growing healthcare awareness and health care spending and the occurrence of Hospital Acquired Infection are anticipated to propel the global sepsis diagnostic market over the forecast years.
The key segments covered in the sepsis diagnostic market are: by technology, pathogen type, method and geography
The sepsis diagnostic market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The sepsis diagnostic market key players are: Roche Diagnostics (Switzerland), Becton, Dickinson and Company (U.S.), Abbott (US), bioMérieux (France), Danaher (US), Luminex (US),  Immunexpress (US), Cepheid Inc (United States)
1. Executive Summary |
2. Global Sepsis Diagnostic Market Introduction |
2.1.Global Sepsis Diagnostic Market - Taxonomy |
2.2.Global Sepsis Diagnostic Market - Definitions |
2.2.1.Technology |
2.2.2.Product |
2.2.3.Pathogen |
2.2.4.Type Analysis |
2.2.5.Region |
3. Global Sepsis Diagnostic Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Sepsis Diagnostic Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Sepsis Diagnostic Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Microbiology |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Molecular Diagnostics |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Immunoassays |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Flow Cytometry |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global Sepsis Diagnostic Market By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Blood Culture Media |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Instruments |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Assays & Reagents |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Sepsis Diagnostic Market By Pathogen, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Bacterial Sepsis |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Gram-negative Bacterial Sepsis |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Gram-positive Bacterial Sepsis |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Fungal Sepsis |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Sepsis Diagnostic Market By Type Analysis, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Laboratory Tests |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Point-Of-Care Tests |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Global Sepsis Diagnostic Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Microbiology |
10.1.2.Molecular Diagnostics |
10.1.3.Immunoassays |
10.1.4.Flow Cytometry |
10.3. Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Bacterial Sepsis |
10.3.2.Gram-negative Bacterial Sepsis |
10.3.3.Gram-positive Bacterial Sepsis |
10.3.4.Fungal Sepsis |
10.3.5.Others |
10.4. Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Laboratory Tests |
10.4.2.Point-Of-Care Tests |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Microbiology |
11.1.2.Molecular Diagnostics |
11.1.3.Immunoassays |
11.1.4.Flow Cytometry |
11.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Blood Culture Media |
11.2.2.Instruments |
11.2.3.Assays & Reagents |
11.3. Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Bacterial Sepsis |
11.3.2.Gram-negative Bacterial Sepsis |
11.3.3.Gram-positive Bacterial Sepsis |
11.3.4.Fungal Sepsis |
11.3.5.Others |
11.4. Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Laboratory Tests |
11.4.2.Point-Of-Care Tests |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Microbiology |
12.1.2.Molecular Diagnostics |
12.1.3.Immunoassays |
12.1.4.Flow Cytometry |
12.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Blood Culture Media |
12.2.2.Instruments |
12.2.3.Assays & Reagents |
12.3. Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Bacterial Sepsis |
12.3.2.Gram-negative Bacterial Sepsis |
12.3.3.Gram-positive Bacterial Sepsis |
12.3.4.Fungal Sepsis |
12.3.5.Others |
12.4. Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Laboratory Tests |
12.4.2.Point-Of-Care Tests |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Microbiology |
13.1.2.Molecular Diagnostics |
13.1.3.Immunoassays |
13.1.4.Flow Cytometry |
13.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Blood Culture Media |
13.2.2.Instruments |
13.2.3.Assays & Reagents |
13.3. Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Bacterial Sepsis |
13.3.2.Gram-negative Bacterial Sepsis |
13.3.3.Gram-positive Bacterial Sepsis |
13.3.4.Fungal Sepsis |
13.3.5.Others |
13.4. Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Laboratory Tests |
13.4.2.Point-Of-Care Tests |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Microbiology |
14.1.2.Molecular Diagnostics |
14.1.3.Immunoassays |
14.1.4.Flow Cytometry |
14.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Blood Culture Media |
14.2.2.Instruments |
14.2.3.Assays & Reagents |
14.3. Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Bacterial Sepsis |
14.3.2.Gram-negative Bacterial Sepsis |
14.3.3.Gram-positive Bacterial Sepsis |
14.3.4.Fungal Sepsis |
14.3.5.Others |
14.4. Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Laboratory Tests |
14.4.2.Point-Of-Care Tests |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Roche Diagnostics (Switzerland) |
15.2.2.Becton, Dickinson and Company (U.S.) |
15.2.3.Abbott (US) |
15.2.4.bioMérieux (France) |
15.2.5.Danaher (US) Luminex (US) |
15.2.6. Immunexpress (US) |
16. Research Methodology |
17. Appendix and Abbreviations |